These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7872994)

  • 1. The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.
    Tsai JJ; Wang TF; Wang SR
    Asian Pac J Allergy Immunol; 1994 Jun; 12(1):65-71. PubMed ID: 7872994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis].
    Numao T; Fukuda T; Akutsu I; Makino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of RP 59227, a platelet-activating factor antagonist, against antigen challenge and eosinophil and neutrophil chemotaxis in asthmatics.
    Townley RG; Eda R; Hopp RJ; Bewtra AK; Gillen MS
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):345-53. PubMed ID: 7812682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.
    Foster AP; Lees P; Cunningham FM
    Res Vet Sci; 1992 Sep; 53(2):223-9. PubMed ID: 1332153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
    Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N; Agrawal DK; Suliaman FA; Townley RG
    Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate.
    Sperling RI; Benincaso AI; Anderson RJ; Coblyn JS; Austen KF; Weinblatt ME
    Arthritis Rheum; 1992 Apr; 35(4):376-84. PubMed ID: 1314609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs.
    Liu B; Zhang H; Li S; Chen W
    Chin Med J (Engl); 1996 Jun; 109(6):467-70. PubMed ID: 9206081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro.
    Shindo K; Koide K; Fukumura M
    Biochem Biophys Res Commun; 1997 Aug; 237(1):146-51. PubMed ID: 9266847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro.
    Czarnetzki BM; Rosenbach T
    Prostaglandins; 1986 May; 31(5):851-8. PubMed ID: 3014612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
    Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis.
    Gaudreault E; Stankova J; Rola-Pleszczynski M
    Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):25-34. PubMed ID: 15789613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New method for the measurement of eosinophil migration.
    Håkansson L; Westerlund D; Venge P
    J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.